Small Caps Today
Priority Technology Turmoil: Shareholder Revolt Explodes Over CEO’s Low-Ball Takeover Bid
Nov 26, 2025

Priority Technology Turmoil: Shareholder Revolt Explodes Over CEO’s Low-Ball Takeover Bid

9' read
Sprout Social Jumps on M&A Chatter — What the Adobe Rumors Really Mean!
Nov 26, 2025

Sprout Social Jumps on M&A Chatter — What the Adobe Rumors Really Mean!

8' read
Nov 26, 2025

Stock Market Today: Wall Street Extends Winning Streak as Dow, S&P 500, Nasdaq Rally into Thanksgiving

US stocks rose on Wednesday, setting up a fourth day win as investors welcomed rising odds of a December rate cut and showed a fresh appetite for Big Tech and risk assets heading into the holiday break.

5' read
Retail Sales Cool as Inflation Jitters and Shutdown Delays Cloud Consumer Outlook
Nov 25, 2025

Retail Sales Cool as Inflation Jitters and Shutdown Delays Cloud Consumer Outlook

4' read
Voyager Technologies Just Bought Estes—Here’s Why It Could Redefine Missile Defense!
Nov 25, 2025

Voyager Technologies Just Bought Estes—Here’s Why It Could Redefine Missile Defense!

7' read
Stock Market Today: Dow Pushes Higher as Tech Stumbles and Fed Cut Bets Take Center Stage
Nov 25, 2025

Stock Market Today: Dow Pushes Higher as Tech Stumbles and Fed Cut Bets Take Center Stage

5' read
Kaltura Goes All-In on Avatars & AI — Will eSelf Make or Break Them?
Nov 25, 2025

Kaltura Goes All-In on Avatars & AI — Will eSelf Make or Break Them?

6' read
​Alphabet’s Race Toward a $4 Trillion Valuation Signals a New Phase of AI Dominance
Nov 24, 2025

​Alphabet’s Race Toward a $4 Trillion Valuation Signals a New Phase of AI Dominance

5' read
Pacira BioSciences Pops As Activist Investor Calls For Sale — What You Need To Know!
Nov 24, 2025

Pacira BioSciences Pops As Activist Investor Calls For Sale — What You Need To Know!

8' read

Business & Market Movers

Stock Market Today: Wall Street Extends Winning Streak as Dow, S&P 500, Nasdaq Rally into Thanksgiving

Priority Technology Turmoil: Shareholder Revolt Explodes Over CEO’s Low-Ball Takeover Bid

Priority Technology Turmoil: Shareholder Revolt Explodes Over CEO’s Low-Ball Takeover Bid

·Nov 26, 2025
Sprout Social Jumps on M&A Chatter — What the Adobe Rumors Really Mean!

Sprout Social Jumps on M&A Chatter — What the Adobe Rumors Really Mean!

·Nov 26, 2025
Voyager Technologies Just Bought Estes—Here’s Why It Could Redefine Missile Defense!

Voyager Technologies Just Bought Estes—Here’s Why It Could Redefine Missile Defense!

·Nov 25, 2025
Stock Market Today: Dow Pushes Higher as Tech Stumbles and Fed Cut Bets Take Center Stage

Stock Market Today: Dow Pushes Higher as Tech Stumbles and Fed Cut Bets Take Center Stage

·Nov 25, 2025

Kaltura Goes All-In on Avatars & AI — Will eSelf Make or Break Them?

Breaking News

s
scdadmin
·Jan 30, 2024

Impact Biomedical, Inc. Announces U.S. Patent Allowance of Laetose™ Technology Entitled “Low Glycemic Sugar Composition.”

Impact Biomedical Inc. (IBIO), in which DSS Inc.(NYSE American: DSS) has a significant investment, is thrilled to announce a milestone in its innovative Laetose™ technology platform. The U.S. Patent and Trademark Office (USPTO) has issued U.S. patent # 11,898,184, entitled “Low Glycemic Sugar Composition” developed within this platform.

3' read
Amesite Launches Implicit Bias Training with Expert Larry Davis Jr.

Amesite Launches Implicit Bias Training with Expert Larry Davis Jr.

scdadmin·Jan 30, 2024
Stock Market Today: Mixed Signals Keep Stocks Muted

Stock Market Today: Mixed Signals Keep Stocks Muted

scdadmin·Jan 04, 2024
Bruush Oral Care Inc. and Arrive Technology Inc. Announce Agreement and Plan of Merger

Bruush Oral Care Inc. and Arrive Technology Inc. Announce Agreement and Plan of Merger

scdadmin·Dec 15, 2023
COP28 Reshapes Oil: Navigating Energy Transition

COP28 Reshapes Oil: Navigating Energy Transition

scdadmin·Dec 14, 2023

Healthcare & Biotech

Nov 24, 2025

Pacira BioSciences Pops As Activist Investor Calls For Sale — What You Need To Know!

Pacira jumped into M&A chatter after investor DOMA Perpetual urged a full sale, arguing the biotech could fetch $66/share. Activist pressure follows solid EXPAREL growth but weak stock performance.

8' read
SUPPER CHANGE YOUR PLANNING POWERS

Join our newsletter

Read and share new perspectives on just about any topic. Everyone’s welcome.
  • 01Create a free account
  • 02Write your story

Tech & Energy

Nov 26, 2025

Priority Technology Turmoil: Shareholder Revolt Explodes Over CEO’s Low-Ball Takeover Bid

Priority Tech faces turmoil as major holder Steamboat blasts the CEO’s go-private bid as too low. With improving results and the CEO controlling 50%+, a high-stakes valuation fight is now underway.

9' read